Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
Explore this paper's citation graph
Summary
This review summarizes information that is pertinent to chemokine receptors as therapeutic targets, the status of low molecular weight antagonists in clinical development, molecular modeling of receptor-small-molecule interactions, and the challenges that face drug discovery and development programs.
- Type
- review
- Published
- 2002-10-01
- Cited by
- 224
- References
- 55
- OpenAlex
- https://openalex.org/W1994415948
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:11498873
Keywords
Chemokine receptor, G protein-coupled receptor, Chemokine, Receptor, Drug discovery
References
- Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion
- Molecular modeling on human CCR5 receptors and complex with CD4 antigens and HIV-1 envelope glycoprotein gp120.
- G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin.
- Attractin: a cub-family protease involved in T cell-monocyte/macrophage interactions.
- Molecular Interactions of Cyclam and Bicyclam Non-peptide Antagonists with the CXCR4 Chemokine Receptor*
- Urokinase Plasminogen Activator and Plasmin Efficiently Convert Hemofiltrate CC Chemokine 1 into Its Active [9–74] Processed Variant1
- Granulocyte-Macrophage Colony Stimulating Factor Up-Regulates CCR1 in Human Neutrophils1
- Molecular basis for the species selectivity of the substance P antagonist CP-96,345.
- Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100.
- Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis.
- CD26, let it cut or cut it down.
- Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist (*)
- Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5.
- Comodulation of CXCR4 and CD26 in Human Lymphocytes*
- The Ligands of CXC Chemokine Receptor 3, I-TAC, Mig, and IP10, Are Natural Antagonists for CCR3*
- Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection through Their Antagonistic Effects on CCR5*
- Chemokines in pathology and medicine
- The role of CD26/DPP IV in chemokine processing.
- An Anti-Inflammatory Drug, Propagermanium, May Target GPI-Anchored Proteins Associated with an MCP-1 Receptor, CCR2
- A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3
Cited by
- The chemokine receptor, CCR5.
- Differential production of inflammatory chemokines by murine dendritic cell subsets.
- Characterization of oak and birch dust-induced expression of cytokines and chemokines in mouse macrophage RAW 264.7 cells.
- Chemokines and inflammation in heart disease: adaptive or maladaptive?
- Prediction of structure, function, and spectroscopic properties of G-protein-coupled receptors : methods and applications.
- Etude du rôle du récepteur de chimiokine CX3CR1 dans la mobilisation monocytaire induite par chimiothérapie
- Chemokine structure and receptor interactions.
- Rôle des progéniteurs dans l’hypertension artérielle pulmonaire humaine et expérimentale
- Heterotrimeric G-protein interactions and activation in chemokine receptor 5 signalling
- FOXP3 regulates metastatic spread of breast cancer via control of expression of CXCR4 chemokine receptor
- Creating chimeras of human G-protein coupled receptors (HGPR40/43) for diabetic drug development
- Orphan chemokine receptors in neuroimmunology : functional and pharmacological analysis of L-CCR and HCR
- Nuclear magnetic resonance studies of CXC chemokine receptor 4 allosteric peptide agonists in solution
- Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins.
- THE EXPRESSION AND CELLULAR LOCALIZATION OF CC-CHEMOKINE RECEPTOR 5 (CCR5) AFTER TRAUMATIC BRAIN INJURY
- Differential Expression of Chemokine MCP-1, MIP-1α, MIP-2 in Lipopolysaccharide-stimulated Neonatal and Adult Rat Brain
- Inhibitors of selectin functions in the treatment of inflammatory skin disorders
- Chemotactic signals released during Burkitt’s lymphoma cell death
- Chemokine Networks and Breast Cancer Metastasis
- Design and synthesis of small nonpeptidergic ligands for the human cytomegalovirus-encoded receptor US28
Related papers
- The chemokine family. Potential therapeutic targets from allergy to HIV infection.
- Heterophilic chemokine receptor interactions in chemokine signaling and biology.
- Slamming the DOR on chemokine receptor signaling: Heterodimerization silences ligand‐occupied CXCR4 and δ‐opioid receptors
- Precision-engineered Peptide and Protein Analogs: Establishing a New Discovery Platform for Potent GPCR Modulators.
- Dimerization of chemokine receptors in living cells: key to receptor function and novel targets for therapy.
- Chemokine decoy receptors: structure-function and biological properties.